| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Lexeo Therapeutics, Inc. (LXEO) have been net sellers, shedding 8,766 shares worth roughly $43K on balance.
Counted by filing, the last 12 months brought no open-market purchases and 16 sales by 7 insiders worth about $746K. The 12 months before that brought 1 open-market purchase by 1 insider worth about $105K and 21 sales by 5 insiders worth about $365K.
1 of the 16 sales in the last 12 months was made under a Rule 10b5-1 trading plan; the rest were not.
The largest open-market purchase in the last two years was 15,000 shares by Paula H Cholmondeley (Director) at an average $6.99 on November 25, 2024, about $105K. Twelve months later LXEO was up 34%.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 376.8K | $1.17M | - | |
| COO | 138.3K | $430.1K | - | |
| CFO | 92.9K | $288.9K | - | |
| Other | 84.9K | $264.1K | - | |
| Other | 72.6K | $225.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Louis Edward Tamayo | Chief Financial Officer | Sell | 4,117 | $4.91 | $20,202.53 | -4.2% | - | - | |
| Aug 18, 2026 | Richard Nolan Townsend74 | Chief Executive Officer | Sell | 3,345 | $4.95 | $16,561.76 | -0.9% | - | - | |
| Aug 18, 2026 | Jose Manuel Otero57 | Chief Operating Officer | Sell | 1,304 | $4.96 | $6,464.06 | -0.9% | - | - | |
| Jul 1, 2026 | Jose Manuel Otero57 | Chief Operating Officer | Sell | 4,666 | $4.48 | $20,903.68 | -3.3% | -23.1% | - | |
| Jul 1, 2026 | Richard Nolan Townsend74 | Chief Executive Officer | Sell | 25,947 | $4.48 | $116,242.56 | -6.4% | -23.1% | - | |
| Jul 1, 2026 | Louis Edward Tamayo | Chief Financial Officer | Sell | 4,641 | $4.49 | $20,838.09 | -4.6% | -23.1% | - | |
| Jul 1, 2026 | Narinder Pal Bhalla | Chief Medical Officer | Sell | 22,306 | $4.42 | $98,592.52 | -21.3% | -23.1% | - | |
| May 18, 2026 | Richard Nolan Townsend74 | Chief Executive Officer | Sell | 3,342 | $5.06 | $16,926.90 | -1.0% | +5.7% | - | |
| May 18, 2026 | Jose Manuel Otero57 | Chief Operating Officer | Sell | 1,302 | $5.07 | $6,606.35 | -1.0% | +5.7% | - | |
| Apr 6, 2026 | Richard Nolan Townsend74 | Chief Executive Officer | Sell10b5-1 | 55,000 | $5.69 | $313,137.00 | -13.9% | -20.3% | - |